Cytosorbents (CTSO) Change in Inventory (2011 - 2026)
Cytosorbents' (CTSO) quarterly Change in Inventory came in at -$789000.0 in Q2 2026, down 208.68% on a YoY basis from $726000.0 in Q2 2025, and down 9.13% quarter-over-quarter from -$723000.0 in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Change in Inventory (2011 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Change in Inventory for 16 consecutive years, with -$789000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Inventory fell 208.68% year-over-year to -$789000.0; the trailing twelve-month figure through Jun 2026 stood at $103000.0 (up 117.02% YoY), and the FY2025 full-year result was $2.5 million, up 608.0% from the prior year.
- Change in Inventory declined to -$789000.0 in Q2 2026 per CTSO's latest filing, from -$723000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.3 million in Q4 2025 and bottomed at -$1.7 million in Q1 2023.
- Historically, Change in Inventory has averaged -$33368.1 across 5 years, with a median of $243774.5 in 2023.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory jumped 472.62% in 2025, then sank 463.32% in 2026.
- Over 5 years, Change in Inventory stood at -$485918.0 in 2022, then jumped by 159.38% to $288549.0 in 2023, then tumbled by 220.26% to -$347000.0 in 2024, then surged by 472.62% to $1.3 million in 2025, then tumbled by 161.02% to -$789000.0 in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$789000.0, -$723000.0, and $1.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 301.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 248.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 240.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 113.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 133.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 23.50 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 36.40 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 73.30 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | -789,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -789,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 322,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | -347,000.00 |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | 600,131.00 |
| Mar 31, 2024 | 429,869.00 |
| Dec 31, 2023 | 288,549.00 |
| Sep 30, 2023 | 978,059.00 |
| Jun 30, 2023 | 297,263.00 |
| Mar 31, 2023 | -1.75 Mn |
| Dec 31, 2022 | -485,918.00 |
| Sep 30, 2022 | -1.05 Mn |
| Jun 30, 2022 | -237,868.00 |
| Mar 31, 2022 | 827,351.00 |
| Dec 31, 2021 | 251,496.00 |
| Sep 30, 2021 | 996,441.00 |